BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32451553)

  • 21. Expression of proteins related to autotaxin-lysophosphatidate signaling in thyroid tumors.
    Shin E; Koo JS
    J Transl Med; 2019 Aug; 17(1):288. PubMed ID: 31455351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis.
    Ninou I; Kaffe E; Müller S; Budd DC; Stevenson CS; Ullmer C; Aidinis V
    Pulm Pharmacol Ther; 2018 Oct; 52():32-40. PubMed ID: 30201409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer.
    Benesch MG; Ko YM; Tang X; Dewald J; Lopez-Campistrous A; Zhao YY; Lai R; Curtis JM; Brindley DN; McMullen TP
    Endocr Relat Cancer; 2015 Aug; 22(4):593-607. PubMed ID: 26037280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomes bind to autotaxin and act as a physiological delivery mechanism to stimulate LPA receptor signalling in cells.
    Jethwa SA; Leah EJ; Zhang Q; Bright NA; Oxley D; Bootman MD; Rudge SA; Wakelam MJ
    J Cell Sci; 2016 Oct; 129(20):3948-3957. PubMed ID: 27557622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Expression Regulation and Biological Function of Autotaxin.
    Zhang X; Li M; Yin N; Zhang J
    Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the placenta in serum autotaxin elevation during maternal cholestasis.
    Macias RIR; Matilla S; Lozano E; Estiú MC; Oude Elferink RP; Marin JJG
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G399-G407. PubMed ID: 29927323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-ordinate regulation of growth factor receptors and lipid phosphate phosphatase-1 controls cell activation by exogenous lysophosphatidate.
    Pilquil C; Ling ZC; Singh I; Buri K; Zhang QX; Brindley DN
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):825-30. PubMed ID: 11709082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autotaxin and LPA receptor signaling in cancer.
    Houben AJ; Moolenaar WH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 3D view of autotaxin.
    Nishimasu H; Ishitani R; Aoki J; Nureki O
    Trends Pharmacol Sci; 2012 Mar; 33(3):138-45. PubMed ID: 22277299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.
    Valdés-Rives SA; González-Arenas A
    Mediators Inflamm; 2017; 2017():9173090. PubMed ID: 29430083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
    Yang F; Chen GX
    World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis.
    Cao P; Walker NM; Braeuer RR; Mazzoni-Putman S; Aoki Y; Misumi K; Wheeler DS; Vittal R; Lama VN
    Sci Rep; 2020 Dec; 10(1):21231. PubMed ID: 33277571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelets, autotaxin and lysophosphatidic acid signalling: win-win factors for cancer metastasis.
    Leblanc R; Houssin A; Peyruchaud O
    Br J Pharmacol; 2018 Aug; 175(15):3100-3110. PubMed ID: 29777586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
    Ryu JM; Han HJ
    Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into the autotaxin/LPA axis in cancer development and metastasis.
    Leblanc R; Peyruchaud O
    Exp Cell Res; 2015 May; 333(2):183-189. PubMed ID: 25460336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling.
    Keune WJ; Hausmann J; Bolier R; Tolenaars D; Kremer A; Heidebrecht T; Joosten RP; Sunkara M; Morris AJ; Matas-Rico E; Moolenaar WH; Oude Elferink RP; Perrakis A
    Nat Commun; 2016 Apr; 7():11248. PubMed ID: 27075612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia.
    Plastira I; Bernhart E; Joshi L; Koyani CN; Strohmaier H; Reicher H; Malle E; Sattler W
    J Neuroinflammation; 2020 Apr; 17(1):127. PubMed ID: 32326963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.